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There is clear evidence documenting the morbidity and
mortality benefit of regular colonoscopy surveillance in
reducing the high risk of primary and metachronous
colorectal cancers associated with Lynch Syndrome (LS)
(Jarvinen et al. 2000). The Australian NHMRC guide-
lines (2005) recommend LS patients undergo a colono-
scopy every 1-2 years (NHMRC 2005). At Peter Mac
yearly colonoscopy screening is usually advised for LS
patients.
The long term adherence rate to colonoscopy in LS
patients as reported in the literature is between 60-88%
(Stoffel et al 2010, Wagner et al 2005). Some factors
have been associated with inadequate LS patient screen-
ing adherence including lack of sedation, inappropriate
advice from managing doctors, financial costs, embar-
rassment and lack of patient time (Bleiker et al 2005).
Whilst not studied, some of these factors may also con-
tribute to a phenomenon known as ‘screening fatigue’,
whereby after one or more normal screening procedures
patients begin to attend less frequently for the recom-
mended screening procedures.
At the Peter Mac patients and their managing doctors
are given GI screening recommendations by the FCC
when the patient receives their gene mutation results.
However, it is unclear whether LS patients continue to
follow the GI screening advice set out by an FCC over
time and whether there is any evidence that ‘screening
fatigue’ exists. Furthermore it is unknown whether dif-
ferences regarding the frequency of colonoscopy
offered/performed, adherence to colonoscopy or quality
of endoscopy exist for patients who participate in a high
risk GI management clinic versus those who are
screened by endoscopists in generalist community based
settings.
The FCC at Peter Mac undertook an audit of the GI
screening practices of 74 confirmed Lynch Syndrome
gene mutation carrier patients from 2006-2010. Of these
patients 27 participate in a high risk GI management
clinic where they receive their GI screening. The addi-
tional 47 patients have GI screening conducted through
either private endosocopy clinics or at public hospitals.
This work will;
❖ Provide a clinical description of our population of
LS patients
❖ Describe the rate of adherence to recommended GI
screening overtime. This is assessed by comparing the
screening practices undertaken with the recommenda-
tions provided by the FCC at the time of their gene test
result. We will also present data about whether updates
of screening recommendations by our FCC were acted
upon by patients/their managing doctors.
❖ Assess for evidence of ‘screening fatigue’
❖ Compare rates of adherence to GI screening prac-
tices between patients attending GI high risk manage-
ment clinics versus patients attending for GI screening
in community settings
❖ Describe the overall colorectal polyp and GI cancer
detection rate
❖ Use colorectal polyp detection also a measure of
quality of colonoscopy
We will make some suggestions for further research
particularly into interventions that may improve adher-
ence to GI screening advice for a population of LS
patients.
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